<p>(A-B) NIH-3T3 cells stably expressing the indicated PML/RARA mutants were treated or not with 10<sup>−6</sup> M ATRA overnight. <i>RARB</i> and <i>Tg II</i> gene expression were analyzed by quantitative RT-PCR. (C-G) The indicated mutant PML/RARA-transduced primary hematopoietic progenitors were treated with or without 10<sup>−6</sup> M ATRA for 14 hours. <i>RARB</i>, <i>Tg II</i>, <i>HCK</i>, <i>PU.1</i> and <i>ID1</i> gene expression was also analyzed by quantitative real-time PCR. All results from quantitative real-time PCR were normalized to <i>β-actin</i>. Results, obtained from three independent experiments, are given as mean ±standard deviations.</p
(A) Sequence analyses of the RARA region of PML-RARA in the RA-resistant patient’s cells. (B) Schema...
<p><b>Copyright information:</b></p><p>Taken from "Orphan nuclear receptor TR2, a mediator of preadi...
<div><p>Because <em>PML-RARA</em>-induced acute promyelocytic leukemia (APL) is a morphologically di...
PML/RARA is the oncoprotein driving acute promyelocytic leukemia (APL). It suppresses genes expressi...
<div><p>PML/RARA is the oncoprotein driving acute promyelocytic leukemia (APL). It suppresses genes ...
PML/RARA is the oncoprotein driving acute promyelocytic leukemia (APL). It suppresses genes expressi...
PML-RAR alpha is the causative oncogene in 5% to 10% of the cases of acute myeloid leukemia. At phys...
Acute promyelocytic leukemia (APL) is characterized by a specific translocation, t(15;17), that fuse...
textabstractPML-RARα is the causative oncogene in 5% to 10% of the cases of acute myeloid leukemia. ...
Promyelocytic leukemia protein PML acts as a tumor suppressor, whereas its chi-meric mutant promyelo...
SummaryAlthough PML-enforced RARA homodimerization allows PML/RARA to bind DNA independently of its ...
<div><p>(A) In the absence of RA, RARα/RXR heterodimers recruit the transcription corepressor (CoR),...
<p>A and B, Q-PCR for <i>RARB2</i> (B RARβ2) and <i>NR2F2</i> (C COUP-TFII) in MCF-7 or T47D cells t...
(A) PML/RARA degradation upon RA treatment in Wt-PML-RARA- and mutant-PML-RARA-transduced cells was ...
<p>NIH-3T3 cells (A and C) or mouse HPCs (B and D) were infected with retroviral constructs expressi...
(A) Sequence analyses of the RARA region of PML-RARA in the RA-resistant patient’s cells. (B) Schema...
<p><b>Copyright information:</b></p><p>Taken from "Orphan nuclear receptor TR2, a mediator of preadi...
<div><p>Because <em>PML-RARA</em>-induced acute promyelocytic leukemia (APL) is a morphologically di...
PML/RARA is the oncoprotein driving acute promyelocytic leukemia (APL). It suppresses genes expressi...
<div><p>PML/RARA is the oncoprotein driving acute promyelocytic leukemia (APL). It suppresses genes ...
PML/RARA is the oncoprotein driving acute promyelocytic leukemia (APL). It suppresses genes expressi...
PML-RAR alpha is the causative oncogene in 5% to 10% of the cases of acute myeloid leukemia. At phys...
Acute promyelocytic leukemia (APL) is characterized by a specific translocation, t(15;17), that fuse...
textabstractPML-RARα is the causative oncogene in 5% to 10% of the cases of acute myeloid leukemia. ...
Promyelocytic leukemia protein PML acts as a tumor suppressor, whereas its chi-meric mutant promyelo...
SummaryAlthough PML-enforced RARA homodimerization allows PML/RARA to bind DNA independently of its ...
<div><p>(A) In the absence of RA, RARα/RXR heterodimers recruit the transcription corepressor (CoR),...
<p>A and B, Q-PCR for <i>RARB2</i> (B RARβ2) and <i>NR2F2</i> (C COUP-TFII) in MCF-7 or T47D cells t...
(A) PML/RARA degradation upon RA treatment in Wt-PML-RARA- and mutant-PML-RARA-transduced cells was ...
<p>NIH-3T3 cells (A and C) or mouse HPCs (B and D) were infected with retroviral constructs expressi...
(A) Sequence analyses of the RARA region of PML-RARA in the RA-resistant patient’s cells. (B) Schema...
<p><b>Copyright information:</b></p><p>Taken from "Orphan nuclear receptor TR2, a mediator of preadi...
<div><p>Because <em>PML-RARA</em>-induced acute promyelocytic leukemia (APL) is a morphologically di...